{"title":"接受体外膜氧合治疗的儿科患者中的非医院感染:系统回顾与元分析》。","authors":"Linjing Li, Weifeng Xu, Weijun Jiang, Yaai Li, Zejia Cheng, Shuzhen Wang, Jiandong Zhou, Rihua Xie, Chunxia Li","doi":"10.1016/j.jhin.2024.10.011","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nosocomial infection has emerged as a significant complication of ECMO treatment and is closely associated with poor prognosis. Studies have shown that paediatric patients are more likely to benefit from ECMO. However, nosocomial infection in paediatric patients has not been comprehensively analysed.</p><p><strong>Aim: </strong>To systematically analyse the incidence, timing, locations, primary pathogens, antibiotic use, and risk factors associated with nosocomial infection and their effects on mortality among paediatric patients undergoing ECMO.</p><p><strong>Methods: </strong>Seven databases were searched for eligible articles; Stata 15.0 was used to calculate the combined effect and 95% confidence interval, and descriptive analysis was employed for other data.</p><p><strong>Findings: </strong>A total of 31 articles were included. The incidence of nosocomial infections was 0.19, 95% CI (0.17-0.22). Respiratory infection was identified as the most common infection type. Staphylococcus species were the predominant pathogens. Antibiotic use was widespread across centres. Prolonged ECMO support was associated with an increased occurrence of nosocomial infections in patients [OR = 1.09, 95% CI (1.06-1.13)]. Nosocomial infection was not associated with an increase in mortality [OR = 1.44, 95% CI (0.98-2.11)].</p><p><strong>Conclusions: </strong>Nosocomial infection was common among paediatric ECMO patients and was affected by various factors. However, nosocomial infection did not increase the risk of mortality.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nosocomial Infection in Paediatric Patients Undergoing Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis.\",\"authors\":\"Linjing Li, Weifeng Xu, Weijun Jiang, Yaai Li, Zejia Cheng, Shuzhen Wang, Jiandong Zhou, Rihua Xie, Chunxia Li\",\"doi\":\"10.1016/j.jhin.2024.10.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nosocomial infection has emerged as a significant complication of ECMO treatment and is closely associated with poor prognosis. Studies have shown that paediatric patients are more likely to benefit from ECMO. However, nosocomial infection in paediatric patients has not been comprehensively analysed.</p><p><strong>Aim: </strong>To systematically analyse the incidence, timing, locations, primary pathogens, antibiotic use, and risk factors associated with nosocomial infection and their effects on mortality among paediatric patients undergoing ECMO.</p><p><strong>Methods: </strong>Seven databases were searched for eligible articles; Stata 15.0 was used to calculate the combined effect and 95% confidence interval, and descriptive analysis was employed for other data.</p><p><strong>Findings: </strong>A total of 31 articles were included. The incidence of nosocomial infections was 0.19, 95% CI (0.17-0.22). Respiratory infection was identified as the most common infection type. Staphylococcus species were the predominant pathogens. Antibiotic use was widespread across centres. Prolonged ECMO support was associated with an increased occurrence of nosocomial infections in patients [OR = 1.09, 95% CI (1.06-1.13)]. Nosocomial infection was not associated with an increase in mortality [OR = 1.44, 95% CI (0.98-2.11)].</p><p><strong>Conclusions: </strong>Nosocomial infection was common among paediatric ECMO patients and was affected by various factors. However, nosocomial infection did not increase the risk of mortality.</p>\",\"PeriodicalId\":3,\"journal\":{\"name\":\"ACS Applied Electronic Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Electronic Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhin.2024.10.011\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, ELECTRICAL & ELECTRONIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhin.2024.10.011","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
摘要
背景:院内感染已成为 ECMO 治疗的一个重要并发症,与预后不良密切相关。研究表明,儿科患者更有可能从 ECMO 中获益。目的:系统分析接受 ECMO 治疗的儿科患者的鼻内感染发生率、时间、地点、主要病原体、抗生素使用、相关风险因素及其对死亡率的影响:方法:在七个数据库中搜索符合条件的文章;使用Stata 15.0计算综合效应和95%置信区间,并对其他数据进行描述性分析:结果:共收录了 31 篇文章。院内感染发生率为 0.19,95% CI (0.17-0.22)。呼吸道感染是最常见的感染类型。葡萄球菌是最主要的病原体。各中心普遍使用抗生素。延长 ECMO 支持时间与患者院内感染发生率增加有关 [OR = 1.09,95% CI (1.06-1.13)]。非医院感染与死亡率增加无关[OR = 1.44,95% CI (0.98-2.11)]:结论:在儿科 ECMO 患者中,院内感染很常见,并受到各种因素的影响。然而,医院内感染并不会增加死亡风险。
Nosocomial Infection in Paediatric Patients Undergoing Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis.
Background: Nosocomial infection has emerged as a significant complication of ECMO treatment and is closely associated with poor prognosis. Studies have shown that paediatric patients are more likely to benefit from ECMO. However, nosocomial infection in paediatric patients has not been comprehensively analysed.
Aim: To systematically analyse the incidence, timing, locations, primary pathogens, antibiotic use, and risk factors associated with nosocomial infection and their effects on mortality among paediatric patients undergoing ECMO.
Methods: Seven databases were searched for eligible articles; Stata 15.0 was used to calculate the combined effect and 95% confidence interval, and descriptive analysis was employed for other data.
Findings: A total of 31 articles were included. The incidence of nosocomial infections was 0.19, 95% CI (0.17-0.22). Respiratory infection was identified as the most common infection type. Staphylococcus species were the predominant pathogens. Antibiotic use was widespread across centres. Prolonged ECMO support was associated with an increased occurrence of nosocomial infections in patients [OR = 1.09, 95% CI (1.06-1.13)]. Nosocomial infection was not associated with an increase in mortality [OR = 1.44, 95% CI (0.98-2.11)].
Conclusions: Nosocomial infection was common among paediatric ECMO patients and was affected by various factors. However, nosocomial infection did not increase the risk of mortality.